We speculate that up-regulation of METTL3 may promote the advancement of ESCC through m6A modification of CASP9 or BIRC3 mRNA, but the modulation of their expression depends on downstream “m6A reader” proteins. The gene discussed is CASP9; the disease is esophageal squamous cell carcinoma.